Generated by GPT-5-mini| Cambridge Crystallographic Data Centre | |
|---|---|
| Name | Cambridge Crystallographic Data Centre |
| Formation | 1965 |
| Founder | Olga Kennard |
| Type | Charity, Database Provider |
| Headquarters | Cambridge |
| Location | United Kingdom |
| Leader title | Director |
| Leader name | Frank Allen |
Cambridge Crystallographic Data Centre is an independent research organisation and data repository specializing in small-molecule and metal–organic crystal structure information. It maintains a curated structural database used by chemists, crystallographers, pharmaceutical companies, and materials scientists in academia and industry. The Centre interacts with major research institutions, publishers, funding agencies, and standards bodies to enable reproducible structural science.
The Centre was founded in 1965 by Olga Kennard following work at University of Cambridge and collaboration with scientists associated with Royal Society initiatives. Early partnerships involved data exchange with laboratories at Harvard University, Massachusetts Institute of Technology, and the University of Oxford. Over decades the Centre engaged with projects linked to National Institutes of Health, European Union research programmes, and repositories such as Protein Data Bank while responding to data demands from GlaxoSmithKline, Pfizer, and AstraZeneca. Directors and staff have included figures who trained at institutions like Imperial College London and University of Manchester, and have contributed to standards discussed at meetings hosted by International Union of Crystallography and Royal Society of Chemistry.
The Centre curates the Cambridge Structural Database, providing deposition, validation, and retrieval services used by researchers at Stanford University, California Institute of Technology, Max Planck Society, and Rutherford Appleton Laboratory. Subscribers from corporations such as Johnson & Johnson, Bayer, and Novartis access search tools and datasets for lead optimisation and solid-form screening. The service interoperates with software developed at Microsoft Research, analytical platforms from Bruker, and visualization tools originating at Lawrence Berkeley National Laboratory. Data pipelines align with recommendations from the Royal Society forums and have been cited in work by authors affiliated with ETH Zurich, University of Tokyo, and Monash University.
Curation workflows draw on standards advocated by International Union of Crystallography and community-driven efforts related to the Fair Data Principles. Validation routines reference conventions promulgated by editors at journals such as Nature, Science, and Journal of the American Chemical Society. The Centre collaborates with editorial boards at Angewandte Chemie and Chemical Communications to harmonize deposition requirements. Quality control incorporates algorithms formerly developed at University of Cambridge groups and methodologies employed in projects at Lawrence Livermore National Laboratory and Brookhaven National Laboratory to detect issues like disorder, twinning, and incorrect atom types.
The Centre produces and supports search, analysis, and visualization tools used alongside packages from Schrödinger, OpenEye Scientific, and ChemAxon. Toolchains enable substructure search and geometric analysis comparable to features found in Gaussian and Materials Studio. Interoperability is provided for file formats used by Crystallographic Information Framework initiatives and by conversion utilities used at Los Alamos National Laboratory. Training materials reference case studies from University of California, Berkeley, Yale University, and University of Illinois Urbana-Champaign and have been presented at conferences such as American Chemical Society national meetings and European Crystallographic Meeting symposia.
The Centre has co-authored publications with researchers at King's College London, University of Sheffield, National University of Singapore, and Peking University. Collaborative projects include crystal engineering studies linked to teams at University of Southampton, polymorphism screening with groups at University of Leeds, and metal–organic framework research with investigators at University of Manchester and University of Groningen. Grant-funded work has involved calls from European Research Council and national programmes administered by UK Research and Innovation. The Centre engages in interdisciplinary networks that include partners from Wellcome Trust, Royal Society of Edinburgh, and British Heart Foundation for translational applications.
Governance structures involve a board with members drawn from academia and industry, including representatives from institutions like University of Cambridge colleges, University of Oxford departments, and corporate partners such as GlaxoSmithKline and AstraZeneca. Funding sources combine subscription revenues, collaborative research grants from agencies such as UK Research and Innovation and European Commission, charitable support linked to foundations like Wellcome Trust, and service agreements with multinational firms including Merck and Takeda. Financial oversight has been discussed in forums convened by Charity Commission for England and Wales and reporting has followed norms reviewed by auditors associated with Institute of Chartered Accountants in England and Wales.
Category:Crystallography Category:Scientific organisations based in the United Kingdom